好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Percentage of Cervical Cord Segments Containing Lesions is Associated with Disability in Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
P3 - Poster Session 3 (11:45 AM-12:45 PM)
1-011

To explore clinically feasible imaging metrics for predicting disability in secondary progressive multiple sclerosis (SPMS)

Spinal cord pathology is known to play a strong role in disability in SPMS, however methods used for its assessment are often time-consuming or require advanced imaging techniques.

137 individuals with SPMS underwent motor testing (timed 25-foot walk, T25FW; 9-hole peg test, 9HPT), cognitive testing (symbol digit modalities test, SDMT), and a survey of walking impairment (multiple sclerosis waking scale, MSWS-12), as part of their routine care from 2018-2023. 108/137 had clinical cervical spine MRIs within 1 year of assessment that included sagittal STIR, axial T2, and axial gradient echo at 1.5 or 3T. An experienced neurologist reviewed each spine MRI and determined the total lesion count and which cord segments (i.e. C1-2, C2-3) had at least one lesion. To determine interrater reliability, two experienced neurologists each reviewed a subset of 20 scans. The correlation coefficient for percentage of cord segments lesioned was excellent (r=0.92). Relationships between clinical and MRI metrics were determined using nonparametric correlations.

Median spinal cord lesion count was 4 (range 0-11). Lesion count was not correlated with any disability measure. Median percentage of segments with lesions was 71% (range 0%-100%). Percentage of segments with lesions was correlated with T25FW (r=0.25, p=0.010) and MSWS12 (r=0.29, p=<0.003), but not 9HPT (p=0.57). When segments were analyzed individually, only lesion presence at C1-2 was associated with worse function across all motor outcomes: T25FW (r=0.22, p=0.020), NHPT (r=0.26, p=0.008), and MSWS12 (r=0.24, p=0.012). Spinal cord lesion burden was not correlated with SDMT.

The presence of lesions at specific spinal cord segments (i.e. C1-2) and the percentage of cervical spinal cord segments containing lesions may carry more prognostic weight for motor outcomes than total lesion count and are more feasible to incorporate into routine clinical practice.

Authors/Disclosures
Daniel Gratch, MD
PRESENTER
Dr. Gratch has nothing to disclose.
Marwa Baalbaki, MD (Rutgers New Jersey Medical School) Dr. Baalbaki has nothing to disclose.
Erin S. Beck, MD (Icahn School of Medicine at Mount Sinai) Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.
James F. Sumowski (Icahn School of Medicine At Mount Sinai) Mr. Sumowski has nothing to disclose.